FE(II) AND DUST INDUCED CARCINOGENESIS
FE(II) AND DUST INDUCED CARCINOGENESIS
批准号:
2277873
负责人:
XI HUANG
金额:
$4.19万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1994
资助国家:
美国
项目状态:
已结题
起止时间:
1994-09-30 至 1996-09-29
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Increasing evidence demonstrates that an excess of lung cancer and stomach
cancer has been observed in workers of iron ore and steel factories. It
has been shown that the incidence of cancer is related to the exposure to
airborne mineral dusts. However, the active compound(s) responsible for
the observed carcinogenicity of mineral dusts has not yet been identified.
Although iron oxide (Fe2O3) particles have been tested and found to
produce little carcinogenicity, this was likely due to the insolubility of
iron oxide in water, even in a slightly low pH medium. Ferrous ion, one
of the most abundant elements in polluted industrial environment, is
capable of producing reactive oxygen species (ROS), and may play an
important role in mineral dust-induced carcinogenesis. Due to the
complexity of iron chemistry, previous studies on iron-induced cell
transformation did not take into account some important chemical factors.
For example, oxidation of Fe(II) to Fe(III) which results in ROS formation
is greatly dependent upon the pH of media. Because of the alkaline pH in
cell growth medium, oxidation of Fe(II) to Fe(III) takes place quickly in
the extracellular medium. Therefore, the short lived ROS resulting from
interaction of Fe(II) and O2 may only damage cell membrane which causes
cell toxicity. In contrast, when Fe(II) is deposited on a particle, and
phagocytized by cells, the released Fe(II) in cells can induce cell
transformation. This is relevant to the mineral dust-induced
carcinogenesis. The aims of this proposed research are to compare the
carcinogenicity of Fe(I) ions in solution and Fe(II)-containing dusts.
Different iron compounds will be tested in SHE cell transformation assay.
To further determine the mechanism of Fe(II) containing dust-induced
carcinogenesis, dichlorofluorescein will be used to estimate oxidant level
in cells. 8-oxo-dG and DNA-protein crosslinkings will be measured to
detect the DNA damage induced by iron compounds. In addition to SHE
cells, we will also investigate the effect of iron compounds on human
tracheal epithelial (HTE) cells. Moreover, we will compare the
responsiveness of oxidative stress-responsive transcription factors, such
as nuclear factor kB and AP-1 to Fe(II) treatment.
期刊论文(2)
专著(0)
科研奖励(0)
会议论文
Chemical reactivity of the carbon-centered free radicals and ferrous iron in coals: role of bioavailable Fe2+ in coal workers pneumoconiosis.
煤炭中以碳为中心的自由基和亚铁的化学反应性:生物可利用的 Fe2 在煤工尘肺病中的作用。
DOI:
10.1080/10715769900300481
发表时间:
1999
期刊:
Free radical research
影响因子:
3.3
作者:
[Huang,X, Zalma,R, Pezerat,H]
通讯作者:
Pezerat,H
Utilization of calcite for the reduction of coal mine dust toxicity
-
批准号:7863384
-
项目类别:
-
资助金额:$29.52万
-
财政年份:2009
-
负责人:XI HUANG
-
依托单位:
EFFICIENT ALGORITHMS FOR PROTEIN TERTIARY STRUCTURE PREDICTION
-
批准号:7725070
-
项目类别:
-
资助金额:$1.74万
-
财政年份:2008
-
负责人:XI HUANG
-
依托单位:
Role of Estrogen and Iron in Breast Cancer
-
批准号:7193116
-
项目类别:
-
资助金额:$16.9万
-
财政年份:2007
-
负责人:XI HUANG
-
依托单位:
Role of Estrogen and Iron in Breast Cancer
-
批准号:7463749
-
项目类别:
-
资助金额:$20.33万
-
财政年份:2007
-
负责人:XI HUANG
-
依托单位:
EFFICIENT ALGORITHMS FOR PROTEIN TERTIARY STRUCTURE PREDICTION
-
批准号:7610018
-
项目类别:
-
资助金额:$1.81万
-
财政年份:2007
-
负责人:XI HUANG
-
依托单位:
IRON, CALCIUM AND OXIDATIVE STRESS IN LUNG INJURY
-
批准号:6335451
-
项目类别:
-
资助金额:$31.44万
-
财政年份:1999
-
负责人:XI HUANG
-
依托单位:
IRON, CALCIUM AND OXIDATIVE STRESS IN LUNG INJURY
-
批准号:6445972
-
项目类别:
-
资助金额:$32.43万
-
财政年份:1999
-
负责人:XI HUANG
-
依托单位:
IRON, CALCIUM AND OXIDATIVE STRESS IN LUNG INJURY
-
批准号:6042278
-
项目类别:
-
资助金额:$31.83万
-
财政年份:1999
-
负责人:XI HUANG
-
依托单位:
FE(II) AND DUST INDUCED CARCINOGENESIS
-
批准号:2277872
-
项目类别:
-
资助金额:$4.05万
-
财政年份:1994
-
负责人:XI HUANG
-
依托单位:
国内基金
海外基金
登录
查看更多内容
基于生境成像与深度学习联合临床特征构建II型卵巢癌术前淋巴结转移预测模型的研究
-
批准号:2026JJ81984
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:杨石平
-
依托单位:
青蒿琥酯协同TROP2/线粒体级联靶向的NIR-II多模态诊疗用于晚期TNBC精准诊断与治疗的机制研究
-
批准号:2026JJ30126
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:杨沙
-
依托单位:
鸡软骨非变性II型胶原高效制备和靶向递送的关键技术开发与应用示范
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:赵子方
-
依托单位:
苏合颗粒治疗慢性萎缩性胃炎的临床(II期)评价关键技术研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:蒋晓波
-
依托单位:
医工融合策略下的新型NIR-II有机探针用于中晚期肝癌精准诊断与协同治疗
-
批准号:2026JJ30093
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:陈国栋
-
依托单位:
用于肺纤维化实时动态监测的NIR-II稀土纳米探针研究
-
批准号:JCZRLH202600246
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
以数据与知识双驱动的NIR-II荧光成像智能分析新范式与基础算法
-
批准号:JCZRMS202600521
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
桥粒斑蛋白调控II型肺泡上皮细胞凋亡易感性而促进特发性肺纤维化形成的机制研究
-
批准号:2026JJ70015
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:彭菲
-
依托单位:
光敏型钌(II)配合物与喜树碱协同给药抗肝癌活性及作用机制研究
-
批准号:2026JJ81924
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:谷依盈
-
依托单位:
草鱼免疫球蛋白与GCRV-II互作机制及高效疫苗创制
-
批准号:JCZRQNA202600094
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位: